RE:RE:RE:PwC sees continuation of US$ 5 to 15 Billion Bio M&A DealsI am reposting this header to remind those that pelareorep is a platform technology that can be potentially used in multple indications rather than in just one or two and that ONCY's valuation is much greater than some on this and other message boards have been speculating.